News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
8th INT’L BIO FORUM & BIO EXPO JAPAN: ES Cell/iPS Cell to Tissue Engineering
June 10, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO--(BUSINESS WIRE)--It is still fresh in our minds the day President Obama lifted an eight-year-old ban on embryonic stem cell research, signing an executive order, calling it as “an important step in advancing the cause of science in America.”
Twitter
LinkedIn
Facebook
Email
Print
Events
Asia
MORE ON THIS TOPIC
Alzheimer’s disease
CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’s
November 18, 2026
·
6 min read
·
Heather McKenzie
Cell therapy
Pfizer launches into autoimmune CAR T with China’s Starna in up to $2.6B deal
November 18, 2026
·
1 min read
·
Annalee Armstrong
China
In China’s shadow, Pfizer CEO calls for AI savings to bolster Big Pharma
November 18, 2026
·
1 min read
·
Annalee Armstrong
Alzheimer’s disease
CTAD 2026: AriBio’s Alzheimer’s candidate slows cognitive decline as monotherapy
November 17, 2026
·
3 min read
·
Nick Paul Taylor